| 1 | 1311213 | Histogenetic correlations between subcategories of small noncleaved cell lymphomas. | Blood | 1992 Mar 1 |
1 |
| 2 | 1339299 | Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas. | Blood | 1992 Jan 1 |
1 |
| 3 | 1374590 | Expression of the bcl-2 gene product in follicular lymphoma. | Am J Pathol | 1992 May |
1 |
| 4 | 1375120 | Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. | Blood | 1992 Jun 1 |
3 |
| 5 | 1378321 | Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. | Blood | 1992 Jul 15 |
1 |
| 6 | 1427749 | Expression of the bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. | Hum Pathol | 1992 Nov |
1 |
| 7 | 1458483 | Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. | Cancer Res | 1992 Dec 15 |
2 |
| 8 | 1459737 | Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines. | Int J Cancer | 1992 Dec 2 |
2 |
| 9 | 1502141 | Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells. | Proc Natl Acad Sci U S A | 1992 Aug 15 |
2 |
| 10 | 1588282 | BCL2 oncogene translocation is mediated by a chi-like consensus. | J Exp Med | 1992 Jun 1 |
1 |
| 11 | 1633729 | Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. | Cytometry | 1992 |
2 |
| 12 | 1654915 | Gene rearrangements detected by nonradioactive digoxigenin-labeled DNA probes. | Anal Quant Cytol Histol | 1991 Jun |
1 |
| 13 | 1899539 | Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction. | Am J Pathol | 1991 Feb |
1 |
| 14 | 2011401 | Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT. | Oncogene | 1991 Mar |
2 |
| 15 | 2114553 | Small G proteins are expressed ubiquitously in lymphoid cells and do not correspond to Bcl-2. | Nature | 1990 Jul 12 |
4 |
| 16 | 2119549 | BCL-2 alpha encodes a novel small molecular weight GTP binding protein. | Adv Enzyme Regul | 1990 |
3 |
| 17 | 2121338 | Role of bcl-2 in growth factor triggered signal transduction. | Cancer Res | 1990 Nov 15 |
7 |
| 18 | 2176281 | Potential Z-DNA elements surround the breakpoints of chromosome translocation within the 5' flanking region of bcl-2 gene. | Oncogene | 1990 Nov |
2 |
| 19 | 2194586 | Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma. | Blood | 1990 Jul 1 |
1 |
| 20 | 2208117 | Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. | Cancer Res | 1990 Oct 15 |
7 |
| 21 | 2263590 | Polymerase chain reaction for bcl-2 in diagnostic lymph node biopsies. | Mod Pathol | 1990 Nov |
1 |
| 22 | 2478890 | The bcl-2 gene encodes a novel G protein. | Nature | 1989 Nov 9 |
2 |
| 23 | 2543982 | Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells. | Proc Natl Acad Sci U S A | 1989 Jun |
1 |
| 24 | 2554236 | Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell. | Oncogene | 1989 Nov |
2 |
| 25 | 2771409 | Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14;18) chromosomes. | Oncogene Res | 1989 |
5 |
| 26 | 3285301 | Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene. | Oncogene Res | 1988 Feb |
2 |
| 27 | 7472523 | Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. | J Neurosci | 1995 Nov |
1 |
| 28 | 7474920 | Hodgkin cells accumulate mRNA for bcl-2. | Lab Invest | 1995 Oct |
2 |
| 29 | 7488387 | Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value. | APMIS | 1995 Sep |
2 |
| 30 | 7503812 | Bcl-2 functions in an antioxidant pathway to prevent apoptosis. | Cell | 1993 Oct 22 |
4 |
| 31 | 7508535 | Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. | Leukemia | 1994 Feb |
1 |
| 32 | 7517174 | Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. | Cell Growth Differ | 1994 Mar |
2 |
| 33 | 7519477 | Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. | Blood | 1994 Aug 15 |
1 |
| 34 | 7519782 | The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. | Proc Natl Acad Sci U S A | 1994 Aug 2 |
1 |
| 35 | 7524301 | Bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype. | Am J Clin Pathol | 1994 Oct |
1 |
| 36 | 7526093 | High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. | Leukemia | 1994 Nov |
4 |
| 37 | 7532659 | Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. | J Immunol | 1995 Mar 1 |
1 |
| 38 | 7536895 | Programmed cell death and Bcl-2 protection in very low oxygen. | Nature | 1995 Apr 27 |
2 |
| 39 | 7539458 | Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. | J Clin Invest | 1995 Jun |
4 |
| 40 | 7540278 | Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. | Oncogene | 1995 Jun 15 |
1 |
| 41 | 7541577 | Implication of cyclosporine in up-regulation of Bcl-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipients. | Transplantation | 1995 Jun 27 |
4 |
| 42 | 7544648 | Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. | Blood | 1995 Sep 1 |
1 |
| 43 | 7545682 | Regulation of the Fas apoptotic cell death pathway by Abl. | J Biol Chem | 1995 Sep 22 |
1 |
| 44 | 7547679 | Tumor necrosis factor-alpha up-regulates Bcl-2 expression and decreases calcium-dependent apoptosis in human B cell lines. | Int Immunol | 1995 Apr |
9 |
| 45 | 7553620 | bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. | Cancer Res | 1995 Oct 15 |
1 |
| 46 | 7553653 | Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. | Cancer Res | 1995 Oct 15 |
1 |
| 47 | 7557262 | Protein kinase C involvement in apoptosis. | Gen Pharmacol | 1995 Sep |
2 |
| 48 | 7558935 | Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression. | Hum Immunol | 1995 Jul |
1 |
| 49 | 7564507 | Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells. | Leukemia | 1995 Oct |
9 |
| 50 | 7585531 | BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. | Cancer Res | 1995 Nov 1 |
2 |